No Major Change in vCJD Agent Strain after Blood Transfusion
Author Information
Author(s): Bishop Matthew T., Ritchie Diane L., Will Robert G., Ironside James W., Head Mark W., Thomson Val, Bruce Moira, Manson Jean C.
Primary Institution: National CJD Surveillance Unit, University of Edinburgh
Hypothesis
Has there been any alteration in the vCJD agent following secondary transmission via blood transfusion?
Conclusion
The study suggests that the strain characteristics of vCJD have not significantly changed due to secondary transmission through blood transfusion.
Supporting Evidence
- The strain transmission properties of blood transfusion associated vCJD infection show remarkable similarities to the strain of vCJD associated with BSE.
- Clinical signs of TSE in transgenic mice were rare and occurred after long incubation periods.
- The study confirms that the agent strain properties of primary and secondary vCJD cases are similar in transmission studies.
Takeaway
This study looked at whether a disease called vCJD changes when passed from one person to another through blood. It found that it doesn't change much.
Methodology
Mice were inoculated with material from the first case of transfusion-associated vCJD infection to study strain characteristics.
Limitations
The study primarily used mouse models, which may not fully replicate human disease characteristics.
Participant Demographics
The study involved transgenic and wild-type mice, with no human participants.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website